Color-coded interbody device approved by FDA

Aurora Spine received FDA clearance for its Dexa Solo-LTM anterior lumbar fusion device on the heels of record first-quarter sales.

Advertisement

The Dexa Solo-LTM is a standalone device for anterior and lateral lumbar interbody fusion, It’s also the first color-coded bone-mimicking structure implant on the market and is designed to help physicians match the implant to a patient’s bone quality and density, the company said in a June 6 news release.

Aurora Spine  in May said its first quarter 2022 sales were the highest in its history.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.